Nurse Practitioner, Community Health · Binghamton, NY
NPI
1568750651
Since 2011
Specialty
Nurse Practitioner, Community Health
Code 363LC1500X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
33 Mitchell Ave, Suite 102
Binghamton, NY, 13903
Phone (607) 762-3281
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
526 services
Medicare patients, 2024
124
Average age 62
Drug cost, 2024
$5.0M
11,173 prescriptions
Company payments, 2025
$2,077
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott R Rosman was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 190 times for 99 patients. In total Scott R Rosman billed 526 services in 19 codes, and Medicare paid $18K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 190 | 99 | $10.13 | $1,925 |
| 99214 Office E&M - Established | Facility | 167 | 90 | $54.77 | $9,146 |
| 99213 Office E&M - Established | Facility | 102 | 67 | $37.16 | $3,791 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 19 | 19 | $106.57 | $2,025 |
By year: 2022 $33K for 915 services; 2023 $16K for 361 services; 2024 $18K for 526 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott R Rosman prescribed most often to Medicare patients was Atorvastatin Calcium, with 473 prescriptions and refills. In total Scott R Rosman wrote 11,173 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 473 | 1,141 | 132 | $4,100 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 385 | 393 | 44 | $1.5M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 379 | 408 | 76 | $12K |
| Amlodipine Besylate Generic | 326 | 852 | 101 | $2,009 |
| Pantoprazole Sodium Generic | 246 | 514 | 62 | $2,204 |
| Losartan Potassium Generic | 215 | 537 | 58 | $1,949 |
| Levothyroxine Sodium Generic | 211 | 424 | 51 | $1,974 |
| Gabapentin Generic | 180 | 330 | 55 | $2,368 |
| Omeprazole Generic | 173 | 413 | 54 | $1,967 |
| Lisinopril Generic | 169 | 378 | 46 | $1,192 |
| Tamsulosin Hcl Generic | 168 | 357 | 46 | $1,651 |
| Metoprolol Succinate Generic | 164 | 352 | 47 | $1,905 |
| Trazodone Hcl Generic | 136 | 265 | 33 | $1,163 |
| Zolpidem Tartrate Generic | 131 | 139 | 24 | $725 |
| Metformin Hcl Er Metformin Hcl | 130 | 290 | 30 | $1,075 |
Brand drugs: 2,863 claims; generic drugs: 8,197 claims; opioid claims: 339.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott R Rosman $2,077 ($2,077 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $552.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $552 |
| ViiV Healthcare Company GSK | 11 | $324 |
| Gilead Sciences, Inc. GILD | 11 | $194 |
| GlaxoSmithKline, LLC. GSK | 12 | $155 |
| Astellas Pharma US Inc 4503.T | 1 | $135 |
| Exact Sciences Corporation EXAS | 6 | $134 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $120 |
| Merck Sharp & Dohme LLC MRK | 5 | $102 |
| Novo Nordisk Inc NVO | 3 | $74.73 |
| Amgen Inc. AMGN | 3 | $53.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.